Skip to main content
Erschienen in: Inflammation 3/2017

16.03.2017 | ORIGINAL ARTICLE

Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ

verfasst von: Na Liu, Jin-Xu Zheng, Yuan-Su Zhuang, Zhi-Kui Zhou, Jin-Hua Zhao, Lei Yang

Erschienen in: Inflammation | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Schisandrin B (Sch B), a dibenzocyclooctadiene lignan isolated from Schisandra chinensis (Turcz.) Baill, has been shown to have anti-inflammatory effect. The purpose of this study was to evaluate the effect of Sch B on LPS-induced inflammation in microglia and to investigate the molecular targets of Sch B. BV2 cells were stimulated by LPS in the presence or absence of Sch B. The results showed that the levels of TNF-α, IL-6, IL-1β, and PGE2 upregulated by LPS were significantly suppressed by Sch B. LPS-induced NF-κB activation was also inhibited by Sch B. Furthermore, Sch B was found to upregulate the expression of PPAR-γ in a concentration-dependent manner. In addition, the inhibition of Sch B on TNF-α, IL-6, IL-1β, and PGE2 production were reversed by PPAR-γ antagonist GW9662. In conclusion, these results suggested that Sch B inhibited LPS-induced inflammatory response by activating PPAR-γ.
Literatur
1.
Zurück zum Zitat Nimmerjahn, A., F. Kirchhoff, and F. Helmchen. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314–1318.CrossRefPubMed Nimmerjahn, A., F. Kirchhoff, and F. Helmchen. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314–1318.CrossRefPubMed
2.
Zurück zum Zitat Ransohoff, R.M., and V.H. Perry. 2009. Microglial physiology: unique stimuli, specialized responses. Annual Review of Immunology 27: 119–145.CrossRefPubMed Ransohoff, R.M., and V.H. Perry. 2009. Microglial physiology: unique stimuli, specialized responses. Annual Review of Immunology 27: 119–145.CrossRefPubMed
3.
Zurück zum Zitat Kang, S.Y., H.W. Jung, M.Y. Lee, H.W. Lee, S.W. Chae, and Y.K. Park. 2014. Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia. Chinese Journal of Natural Medicines 12: 573–581.CrossRefPubMed Kang, S.Y., H.W. Jung, M.Y. Lee, H.W. Lee, S.W. Chae, and Y.K. Park. 2014. Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia. Chinese Journal of Natural Medicines 12: 573–581.CrossRefPubMed
4.
Zurück zum Zitat Glass, C.K., K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918–934.CrossRefPubMedPubMedCentral Glass, C.K., K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918–934.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Teeling, J.L., and V.H. Perry. 2009. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158: 1062–1073.CrossRefPubMed Teeling, J.L., and V.H. Perry. 2009. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158: 1062–1073.CrossRefPubMed
6.
Zurück zum Zitat Hebert, L.E., L.A. Beckett, P.A. Scherr, and D.A. Evans. 2001. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders 15: 169–173.CrossRefPubMed Hebert, L.E., L.A. Beckett, P.A. Scherr, and D.A. Evans. 2001. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders 15: 169–173.CrossRefPubMed
7.
Zurück zum Zitat Qian, L., P.M. Flood, and J.S. Hong. 2010. Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy. Journal of Neural Transmission 117: 971–979.CrossRefPubMedPubMedCentral Qian, L., P.M. Flood, and J.S. Hong. 2010. Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy. Journal of Neural Transmission 117: 971–979.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Minghetti, L. 2005. Role of inflammation in neurodegenerative diseases. Current Opinion in Neurology 18: 315–321.CrossRefPubMed Minghetti, L. 2005. Role of inflammation in neurodegenerative diseases. Current Opinion in Neurology 18: 315–321.CrossRefPubMed
9.
Zurück zum Zitat Zeng, K.W., T. Zhang, H. Fu, G.X. Liu, and X.M. Wang. 2012. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-kappa B signaling pathway in lipopolysaccharide-induced microglia. European Journal of Pharmacology 692: 29–37.CrossRefPubMed Zeng, K.W., T. Zhang, H. Fu, G.X. Liu, and X.M. Wang. 2012. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-kappa B signaling pathway in lipopolysaccharide-induced microglia. European Journal of Pharmacology 692: 29–37.CrossRefPubMed
10.
Zurück zum Zitat Leong, P.K., and K.M. Ko. 2015. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo. BioFactors 41: 314–323.CrossRefPubMed Leong, P.K., and K.M. Ko. 2015. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo. BioFactors 41: 314–323.CrossRefPubMed
11.
Zurück zum Zitat Cai, Z., J. Liu, H. Bian, J. Cai, and G. Zhu. 2016. Suppression of P2X7/NF-kappaB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Archives of Pharmacal Research 39: 499–507.CrossRefPubMed Cai, Z., J. Liu, H. Bian, J. Cai, and G. Zhu. 2016. Suppression of P2X7/NF-kappaB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Archives of Pharmacal Research 39: 499–507.CrossRefPubMed
12.
Zurück zum Zitat Liu, W., Y. Liu, Z. Wang, T. Yu, Q. Lu, and H. Chen. 2015. Suppression of MAPK and NF-kappa B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease. Pharmazie 70: 598–603.PubMed Liu, W., Y. Liu, Z. Wang, T. Yu, Q. Lu, and H. Chen. 2015. Suppression of MAPK and NF-kappa B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease. Pharmazie 70: 598–603.PubMed
13.
Zurück zum Zitat Block, M.L., L. Zecca, and J.S. Hong. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 8: 57–69.CrossRefPubMed Block, M.L., L. Zecca, and J.S. Hong. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 8: 57–69.CrossRefPubMed
15.
Zurück zum Zitat Long-Smith, C.M., A.M. Sullivan, and Y.M. Nolan. 2009. The influence of microglia on the pathogenesis of Parkinson’s disease. Progress in Neurobiology 89: 277–287.CrossRefPubMed Long-Smith, C.M., A.M. Sullivan, and Y.M. Nolan. 2009. The influence of microglia on the pathogenesis of Parkinson’s disease. Progress in Neurobiology 89: 277–287.CrossRefPubMed
16.
Zurück zum Zitat Tweedie, D., K. Sambamurti, and N.H. Greig. 2007. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Current Alzheimer Research 4: 378–385.CrossRefPubMed Tweedie, D., K. Sambamurti, and N.H. Greig. 2007. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Current Alzheimer Research 4: 378–385.CrossRefPubMed
17.
Zurück zum Zitat Karin, M., and F.R. Greten. 2005. NF kappa B: Linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology 5: 749–759.CrossRefPubMed Karin, M., and F.R. Greten. 2005. NF kappa B: Linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology 5: 749–759.CrossRefPubMed
18.
Zurück zum Zitat Wang, H.Y., H. Wang, J.H. Wang, Q. Wang, Q.F. Ma, and Y.Y. Chen. 2015a. Protocatechuic Acid Inhibits Inflammatory Responses in LPS-Stimulated BV2 Microglia via NF-kappa B and MAPKs Signaling Pathways. Neurochemical Research 40: 1655–1660.CrossRefPubMed Wang, H.Y., H. Wang, J.H. Wang, Q. Wang, Q.F. Ma, and Y.Y. Chen. 2015a. Protocatechuic Acid Inhibits Inflammatory Responses in LPS-Stimulated BV2 Microglia via NF-kappa B and MAPKs Signaling Pathways. Neurochemical Research 40: 1655–1660.CrossRefPubMed
19.
Zurück zum Zitat Chow, Y.L., K.H. Lee, S. Vidyadaran, N.H. Lajis, M.N. Akhtar, D.A. Israf, and A. Syahida. 2012. Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappa B signalling pathway. International Immunopharmacology 12: 657–665.CrossRefPubMed Chow, Y.L., K.H. Lee, S. Vidyadaran, N.H. Lajis, M.N. Akhtar, D.A. Israf, and A. Syahida. 2012. Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappa B signalling pathway. International Immunopharmacology 12: 657–665.CrossRefPubMed
20.
Zurück zum Zitat Zhu, J.Y., L. Jiang, Y.Q. Liu, W.Y. Qian, J.L. Liu, J. Zhou, R. Gao, H. Xiao, and J. Wang. 2015. MAPK and NF-kappa B Pathways Are Involved in Bisphenol A-Induced TNF-alpha and IL-6 Production in BV2 Microglial Cells. Inflammation 38: 637–648.CrossRefPubMed Zhu, J.Y., L. Jiang, Y.Q. Liu, W.Y. Qian, J.L. Liu, J. Zhou, R. Gao, H. Xiao, and J. Wang. 2015. MAPK and NF-kappa B Pathways Are Involved in Bisphenol A-Induced TNF-alpha and IL-6 Production in BV2 Microglial Cells. Inflammation 38: 637–648.CrossRefPubMed
21.
Zurück zum Zitat Wang, Y.M., J. Zhou, S. Fu, C. Wang, and B. Zhou. 2015b. Preventive Effects of Protocatechuic Acid on LPS-Induced Inflammatory Response in Human Gingival Fibroblasts via Activating PPAR-gamma. Inflammation 38: 1080–1084.CrossRefPubMed Wang, Y.M., J. Zhou, S. Fu, C. Wang, and B. Zhou. 2015b. Preventive Effects of Protocatechuic Acid on LPS-Induced Inflammatory Response in Human Gingival Fibroblasts via Activating PPAR-gamma. Inflammation 38: 1080–1084.CrossRefPubMed
22.
Zurück zum Zitat Takagi, T., Y. Naito, N. Tomatsuri, O. Handa, H. Ichikawa, N. Yoshida, and T. Yoshikawa. 2002. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappa B-cytokine cascade. Redox Report 7: 283–289.CrossRefPubMed Takagi, T., Y. Naito, N. Tomatsuri, O. Handa, H. Ichikawa, N. Yoshida, and T. Yoshikawa. 2002. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappa B-cytokine cascade. Redox Report 7: 283–289.CrossRefPubMed
23.
Zurück zum Zitat Zhang, Y.F., X.L. Zou, J. Wu, X.Q. Yu, and X. Yang. 2015. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-gamma Agonist, Attenuates Inflammation Via NF-kappa B Inhibition in Lipopolysaccharide-Induced Peritonitis. Inflammation 38: 2105–2115.CrossRefPubMed Zhang, Y.F., X.L. Zou, J. Wu, X.Q. Yu, and X. Yang. 2015. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-gamma Agonist, Attenuates Inflammation Via NF-kappa B Inhibition in Lipopolysaccharide-Induced Peritonitis. Inflammation 38: 2105–2115.CrossRefPubMed
24.
Zurück zum Zitat Corsi, L., B.M. Dongmo, and R. Avallone. 2015. Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line. International Journal of Food Sciences and Nutrition 66: 293–299.CrossRefPubMed Corsi, L., B.M. Dongmo, and R. Avallone. 2015. Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line. International Journal of Food Sciences and Nutrition 66: 293–299.CrossRefPubMed
Metadaten
Titel
Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ
verfasst von
Na Liu
Jin-Xu Zheng
Yuan-Su Zhuang
Zhi-Kui Zhou
Jin-Hua Zhao
Lei Yang
Publikationsdatum
16.03.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0544-2

Weitere Artikel der Ausgabe 3/2017

Inflammation 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.